Qunfeng Wu

620 total citations
19 papers, 403 citations indexed

About

Qunfeng Wu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Qunfeng Wu has authored 19 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Qunfeng Wu's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Hepatitis B Virus Studies (4 papers) and Virus-based gene therapy research (3 papers). Qunfeng Wu is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Hepatitis B Virus Studies (4 papers) and Virus-based gene therapy research (3 papers). Qunfeng Wu collaborates with scholars based in United States and China. Qunfeng Wu's co-authors include Chen Liu, Kien Pham, Keith D. Robertson, Huanchun Chen, Thu Le Trinh, William Puszyk, Jeong‐Heon Lee, Ryan A. Hlady, Xilin Xiao and Weihong Tan and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Hepatology.

In The Last Decade

Qunfeng Wu

19 papers receiving 397 citations

Peers

Qunfeng Wu

IMMUN

EPIDE

HEPAT

Junwei Hou China

Gang Long China

S Mochizuki Japan

Fanching Lin United States

Sandra Wagner Germany

Tsubasa Munakata Japan

Xiugen Zhang United States

Yujia Zhai China

Adrian Onu Romania

Marla Lay United States

Junwei Hou China

Qunfeng Wu

367 ×1.6

157 ×2.0

IMMUN

90 ×1.2

EPIDE

57 ×0.9

42 ×0.7

HEPAT

Citations per year, relative to Qunfeng Wu Qunfeng Wu (= 1×) peers Junwei Hou

Countries citing papers authored by Qunfeng Wu

Since Specialization

Citations

This map shows the geographic impact of Qunfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunfeng Wu more than expected).

Fields of papers citing papers by Qunfeng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunfeng Wu. The network helps show where Qunfeng Wu may publish in the future.

Co-authorship network of co-authors of Qunfeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qunfeng Wu. A scholar is included among the top collaborators of Qunfeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunfeng Wu. Qunfeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Yang, Lei, Kien Pham, Yibo Xi, et al.. (2025). Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma. PLoS ONE. 20(1). e0317401–e0317401. 5 indexed citations

Hlady, Ryan A., Xia Zhao, Louis Y. El Khoury, et al.. (2021). Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance. Hepatology. 75(4). 983–996. 26 indexed citations

Bliss, Sarah A., Seda Ayer, Garima Sinha, et al.. (2020). Neuroimmune/Hematopoietic Axis with Distinct Regulation by the High-Mobility Group Box 1 in Association with Tachykinin Peptides. The Journal of Immunology. 204(4). 879–891. 7 indexed citations

Wu, Qunfeng, et al.. (2019). Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination. The Journal of Steroid Biochemistry and Molecular Biology. 197. 105524–105524. 9 indexed citations

Hlady, Ryan A., Aishwarya Sathyanarayan, Joyce J. Thompson, et al.. (2018). Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma. Hepatology. 69(2). 639–652. 71 indexed citations

Wu, Qunfeng, Liya Pi, Thu Le Trinh, et al.. (2017). A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma. Molecular Therapy. 25(10). 2299–2308. 30 indexed citations

Wu, Qunfeng, et al.. (2016). Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma. Gastroenterology Research and Practice. 2016. 1–9. 7 indexed citations

Trinh, Thu Le, Qunfeng Wu, Lung‐Ji Chang, Mitchell Ho, & Chen Liu. (2016). Abstract 2316: GPC3-specific chimeric antigen receptor T cell in combination with Sorafenib as a novel therapeutic treatment for hepatocellular carcinoma. Cancer Research. 76(14_Supplement). 2316–2316. 3 indexed citations

Zuo, Chaohui, Nianli Liu, Darong Yang, et al.. (2015). Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma. Experimental Cell Research. 333(2). 316–326. 13 indexed citations

10.

Zuo, Chaohui, Man Xia, Jingshi Liu, et al.. (2015). Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection. Asian Pacific Journal of Cancer Prevention. 16(1). 245–251. 16 indexed citations

11.

Chen, Ying, Ting Zhang, Qunfeng Wu, et al.. (2015). [Cloning, expression and bioinformatics analysis of pyruvate dehydrogenase of Echinococcus granulosus].. PubMed. 27(4). 376–80. 2 indexed citations

12.

Trinh, Thu Le, Guizhi Zhu, Xilin Xiao, et al.. (2015). A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy. PLoS ONE. 10(11). e0136673–e0136673. 69 indexed citations

13.

Yuan, Hong, Darong Yang, Man Xia, et al.. (2015). ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma.. PubMed. 8(10). 17140–50. 19 indexed citations

14.

Zuo, Chaohui, Man Xia, Qunfeng Wu, et al.. (2014). Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review). Oncology Letters. 9(2). 527–534. 16 indexed citations

15.

Xu, Jinfang, Ping Qian, Qunfeng Wu, et al.. (2014). Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo. Antiviral Research. 109. 22–29. 26 indexed citations

16.

Wu, Qunfeng, Fu-Lai Yu, Jinfang Xu, et al.. (2014). Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model. Veterinary Microbiology. 171(1-2). 93–101. 16 indexed citations

17.

Wu, Qunfeng, Fengqin Xu, Liurong Fang, et al.. (2012). Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus. Journal of Virological Methods. 187(2). 251–258. 11 indexed citations

18.

Wu, Qunfeng, Shaobo Xiao, Huiying Fan, et al.. (2011). Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine. Antiviral Research. 92(3). 493–496. 9 indexed citations

19.

Wu, Qunfeng, Liurong Fang, Bin Li, et al.. (2009). A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Molecular Immunology. 46(11-12). 2210–2217. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact